Patent ID: 8226558

Claim:
A glucose monitoring system comprising: a subcutaneous in vivo sensor for monitoring a glucose level of an interstitial fluid of a user; a sensor control unit coupled to the sensor to output one or more signals associated with the monitored glucose level of the interstitial fluid of the user; and a receiver/display unit in communication with the sensor control unit and comprising: a receiver to receive the outputted one or more signals associated with the monitored glucose level of the interstitial fluid of the user from the sensor control unit; an input device to receive an input from the user, wherein the input comprises, a medication sensitivity, drug delivery information, a food intake, and an exercise level; a processor to evaluate the one or more signals received by the receiver to produce a first set of results comprising: (i) the glucose level in interstitial fluid of the user, (ii) a rate of change of the glucose level, and (iii) an acceleration in the rate of change of the glucose level, wherein the processor further evaluates the input from the user and the first set of results to determine a dose of a medication; and a display in communication with the processor.